Showing 1 - 10 of 284
Although there are no traditional markets and money prices in the public sector, consumers and providers may respond to signals of organisational performance. We present a simple dynamic model of the demand and supply for elective surgery in the UK National Health Service in which waiting time...
Persistent link: https://www.econbiz.de/10005564520
The underpricing phenomenon of Initial Public Offerings (IPOs) has been widely studied across different stock markets around the world and has often been explained to be a result of asymmetrically distributed information and ex-ante uncertainty. However, as Ritter and Welch (2002) argue, these...
Persistent link: https://www.econbiz.de/10012737272
The overallotment or greenshoe option has become very popular in the German IPO market since its introduction in 1995 and is nowadays an important tool to stabilize IPOs or to issue additional shares in the case of excess demand. Besides providing evidence for the prevalence of price support...
Persistent link: https://www.econbiz.de/10012737765
Persistent link: https://www.econbiz.de/10012740526
The underpricing phenomenon of Initial Public Offerings (IPOs) has been widely studied across different stock markets around the world and has often been explained to be a result of asymmetrically distributed information and ex-ante uncertainty. However, as Ritter and Welch (2002) argue, these...
Persistent link: https://www.econbiz.de/10012769670
Persistent link: https://www.econbiz.de/10005123069
Persistent link: https://www.econbiz.de/10002520278
This article investigates entry and exit in Slovenian manufacturing for the period 1994-2000 using OLS and panel data fixed and random-effects estimations. Private ownership is associated with higher rates of firm exit, suggesting that this ownership structure is related to a higher risk of...
Persistent link: https://www.econbiz.de/10005471805
This paper presents and evaluates pharmaceutical policies in the EU aimed at the rational use of medicines and at keeping pharmaceutical spending under control. Policy makers are growing more aware that by regulating pharmaceutical markets correctly, considerable savings can be achieved without...
Persistent link: https://www.econbiz.de/10011109548
This paper presents and evaluates pharmaceutical policies in the EU aimed at the rational use of medicines and at keeping pharmaceutical spending under control. Policy makers are growing more aware that by regulating pharmaceutical markets correctly, considerable savings can be achieved without...
Persistent link: https://www.econbiz.de/10010584038